The FDA announced on 2014-10-06 that Hospira Inc. is recalling Propofol Injectable Emulsion due to temperature abuse during transit, according to the FDA. The recall affects a single shipment of 2,500 vials distributed nationwide for Vancomycin lots but limited to The Harvard Drug Group in Livonia, MI for the affected lots.
How to tell if you have it
- Brand: Hospira
- Product: Propofol Injectable Emulsion, 1%, 200 mg/20 mL (10 mg/mL), 20 mL Single patient infusion vials
- NDC: 0409-4699-30
- Lot #: 33-750-DJ
- Expiration Date: Exp 1SEP2015
- Quantity: 2,500 vials
The hazard
The products experienced uncontrolled temperature excursions during transit, according to the FDA. This hazard classifies the recall as Class I.
Context
GovInfoNow's records show Hospira Inc. has had 108 other recalls since 2012-04-05. In 2017-04-21, Hospira recalled Infant Dextrose Injection due to hair particulates in syringes. On 2016-11-01, the company recalled Fentanyl Injection because of broken ampule tips risking infection. Other recent recalls of similar products include TerSera's Zoladex Implants (2026-08-31), McKesson's UDENYCA Injection (2026-01-16), and McKesson's Gemcitabine Injection (2026-06-10).